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Instruments for the identification of patients in need of palliative care: a systematic review protocol of 1 
measurement properties 2 
Abstract 3 
Objective: to provide a comprehensive overview of the psychometric properties of available clinician-4 
reported instruments developed to identify patients in need of general and specialized palliative care in 5 
acute care settings. 6 
Introduction: Identification of patients in need of palliative care has been recognized as an area where 7 
many healthcare professionals need guidance. Differentiating between patients who require general 8 
palliative care and patients with more complex conditions who need specialized palliative care is 9 
particularly challenging. To our knowledge, no instrument are available to date to assist healthcare 10 
professionals to make this identification.   11 
Inclusion criteria: Will be included studies reporting : i) instruments aiming to identify patients in need 12 
of PC, ii) sample of adult patients in need of PC in acute care settings, iii) Clinician-reported outcome 13 
measures (ClinROMs), iv) the development process or one or more of its measurement properties. Will 14 
be excluded studies conducted intensive care units, emergency departments, and nursing homes.  15 
Methods: We will search studies published in English and French in: Embase.com, Medline Ovid SP, 16 
Pubmed, and CINAHL EBSCO and other sources, such as Google Scholar, government websites, and 17 
hospice websites. All citations will be screened and selected by two independent reviewers. Data 18 
extraction, quality assessment, and syntheses of included studies will be performed according to the 19 
COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) criteria. 20 
PROSPERO systematic review registration number: CDR42020150074. 21 
Keywords: Identification; palliative care; measurement properties; instruments.  22 
  23 
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Introduction 24 
Patients in need of palliative care (PC) are present in all different care settings. Prevalence varies from 25 
9% to 73% in acute care settings depending on pathologies, co-morbidities or frailty.1-5 An international 26 
prevalence study revealed that the proportion of individuals who died from diseases indicating a need 27 
for palliative care ranged from 38% to 74%.6 According to Murtagh et al.,7 63% to 82% of the population 28 
will need palliative care at some point of their disease trajectory. With the increase of the ageing 29 
population and the number of patients suffering from chronic diseases and polymorbidity, the number 30 
of patients in need of PC is likely to increase further.  31 
When patients do not receive appropriate PC, there is strong evidence of (i) excess hospital mortality - 32 
80% - while the majority of people wish to die at home;8-11 (ii) suboptimal symptom management;12-14 33 
(iii) unplanned hospitalizations with longer hospital stays;15-16 (iv) prescription of inappropriate 34 
treatments due to a lack of anticipative care plans,17-18 and (v) insufficient support for the patient and 35 
their relatives.15, 19-20 Out of all patients in need of PC, about 75% to 80% of them can be cared by non-36 
specialist teams (general PC) and the remaining 20%-25%, may need specialized PC provided by PC 37 
specialists due to the complexity of their conditions.21-23 There is an internationally recognized distinction 38 
between patients requiring "general" versus "specialized" palliative care. General PC are provided by 39 
non-specialized professionals for situations without any element of complexity. Specialized PC are for 40 
patients whose illness is characterized by great clinical instability and/or a high level of psycho-socio-41 
existential suffering, making their situation complex to the point, where non-specialist in PC do not have 42 
the necessary competences to care for them.8, 12 43 
Identification of patients in need of general or specialized PC is a pre-requisite for appropriate 44 
management.24 However, adequate identification is challenging as it relies on an unclear World Health 45 
Organization (WHO) definition which defines PC as “an approach that improves the quality of life of 46 
patients and their families facing the problem associated with life-threatening illness, through the 47 
prevention and relief of suffering by means of early identification and impeccable assessment and 48 
treatment of pain and other problems, physical, psychosocial and spiritual”.25[para.1] This definition does 49 
not allow differentiating between general and specialized PC.26-29 Despite this, experts agree with PC 50 
not being exclusively associated with terminal care and not depending only on patient diagnosis or 51 
prognosis, but also on patients’ needs. They confirm that PC should be initiated early in a patient 52 
disease trajectory.30 The identification of patients in need of PC without a valid tool is sub-optimal 53 
because it occurs mostly at the end of life or only for highly complex situations. 54 
A growing number of instruments exists to help professionals identifying patients in need of PC. These 55 
instruments include criteria concerning the severity of illness, the progression of the disease, and its 56 
associated frailty. Some instruments were designed only for a specific setting, such as the emergency 57 
department or intensive care.31 Although, it is recommended to integrate palliative care early in the 58 
stage of a life-threatening event, treatment goal of patients who require intensive care, is primarily to 59 
sustain vital functions. Instruments designed for PC patients may therefore not be appropriate for this 60 
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population. Other instruments were designed for a specific pathology, for example interstitial lung 61 
disease;32 or for a specific age group such as older people.33 Others were designed for general use.34-62 
36 63 
To implement such an instrument into daily practice it is necessary to select the most suitable one 64 
based on its psychometric properties, particularly validity (measure what it is supposed to measure), 65 
reliability (consistency), and responsiveness (ability to detect change over time).  66 
In palliative care, many patients are not able to fill in a patient-reported outcome to evaluate their own 67 
palliative care needs. For example patients with dementia, any cognitive impairment or delirium, and 68 
those who are not well informed about the stage of their disease, or who have some cultural barriers to 69 
discuss this topic. In this context, it seems important that healthcare professionals carry out this first 70 
screening, which will assist them to engage in discussion with the patient and her/his relatives about 71 
the disease trajectory and their needs, and to give them the most appropriate care. The focus of this 72 
review is therefore on clinician-reported outcome measures (ClinROMs) for the identification of patients 73 
in need of PC. 74 
A preliminary search of MEDLINE, the Cochrane Database of Systematic Reviews, the COSMIN 75 
database, and the JBI Database of Systematic Reviews and Implementation Reports was conducted 76 
and two systematic reviews on the topic were identified.37-38 Both reviews are focused on the inventory 77 
and the description of the available instruments.  78 
Maas et al. completed their systematic review by a survey conducted with European general 79 
practitioners (GPs) to identify non published instruments.37 They carried out their review in only two 80 
databases (PubMed/MEDLINE and Embase) and they focused their searching on articles describing 81 
identification instruments suitable for use in primary care. A narrative approach was used to synthesize 82 
data. Then they compared the content of the different instruments and the identification criteria. Few or 83 
no information are available about the data collection process, the quality assessment of the studies, 84 
the studies’ characteristics and whether authors have been contacted to obtain complementary data. 85 
They found five articles, which described four different instruments. These instruments are: the 86 
RADbout indicators for Palliative Care needs (RADPAC),39 the Residential home palliative care tool,40 87 
the Supportive and Palliative Care Indicators Tool (SPICT) 35 and the Early identification tool for 88 
palliative care patients.41 The complementary survey allowed finding three instruments which had not 89 
been identified in the literature although two of them are widely known, which raises questions about 90 
the quality of the review. These three instruments are: the Prognostic Indicator Guide of the UK-based 91 
Gold Standard Framework (PIG-GSF),34 the NECPAL-CCOMS-ICO36 and the Quick guide.42 Then 92 
instruments were compared. When sensitivity and specificity were reported in the original studies, the 93 
authors of this review mentioned them, but without mentioning any psychometric assessment. None of 94 
the presented instruments distinguishes patients in need of general vs. specialized PC.  95 
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Walsh et al. realized their systematic review following the Preferred Reporting Items for Systematic 96 
Review and Meta-Analysis (PRISMA).38,43 Most of the PRISMA criteria are presented but they did not 97 
perform any systematic evaluation of the psychometric properties and risks of bias. They used a 98 
deductive approach to analyze the content of four instruments to determine the usability and 99 
acceptability in clinical practice. These four instruments are: the Prognostic Indicator Guide of the UK-100 
based Gold Standard Framework (PIG-GSF),34 the NECPAL-CCOMS-ICO;36 the SPICT35 and the 101 
RADPAC.39 They concluded that there is limited evidence these instruments appropriately identify 102 
patients in need of PC early in their illness trajectory. None of the presented instruments distinguishes 103 
patients in need of general vs. specialized PC.  104 
In conclusion, neither of these two reviews included a systematic appraisal of the psychometric 105 
properties of the selected instruments. This justifies the necessity to perform a new systematic review 106 
with the following aim: to provide a comprehensive overview of the psychometric properties of available 107 
clinician-reported instruments developed to identify patients in need of palliative care regardless of the 108 
care setting – except for intensive care units and emergency departments. 109 
Review Question 110 
The question of this review is: what are the measurement properties of instruments that allow the 111 
identification of adult patients in need of palliative care and that can be used in all acute care settings 112 
except for emergency and intensive care units? 113 
Inclusion Criteria 114 
The COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) 115 
guidelines for systematic reviews of measurement properties recommend the following criteria of 116 
inclusion:44 i) the instrument should aim to measure the construct of interest (identification of patients 117 
in need of PC), ii) the study sample should concern the target population of interest (adult patients in 118 
need of PC), iii) the study should concern the type of measurement instrument of interest (ClinROMs), 119 
iv) the aim of the study should be the development of a measurement instrument or the evaluation of 120 
one or more of its measurement properties. 121 
Population 122 
This review will consider studies including adult patients with life limiting cancer or non-cancer illness 123 
(e.g. chronic, progressive, incurable illness likely to cause death), in palliative care or in end of life care 124 
situation. Patients will need to be hospitalized in any acute care settings, except intensive care units, 125 
emergency departments and nursing home.  126 
Instrument and construct 127 
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This review will consider studies presenting any measurement property of clinician-reported outcome 128 
measurement (ClinROMs), allowing the identification of patients in need of generalized or specialized 129 
palliative care (construct of interest). As those instruments have to be used by others professionals than 130 
physicians, we will include instruments comprising general indicators of decline and frailty (e.g. , but 131 
exclude biological markers that require specific investigation or exam (e.g. serum albumin). Due to the 132 
necessity to identify patients in need of PC as early as possible, prognostic instrument will be excluded.  133 
Inclusion criteria: palliative care, adult patient (>18yrs), all pathologies (cancer/non-cancer), acute care 134 
settings, instruments/tools for identification, studies reporting the development of instruments or one or 135 
more measurement properties of instruments: content validity, reliability, responsiveness. 136 
Exclusion criteria: disabled persons, intensive care, emergency, nursing homes, caregivers, pediatric 137 
patients, neonates, prognosis instrument, surprise question only, biomarkers, instrument used as an 138 
outcome measurement with no measurement properties reported.  139 
Outcomes 140 
The outcomes will include the measurement properties of the assessed instruments. They refer to the 141 
psychometric properties of the identification instruments. 142 
The COnsensus-based Standards for the selection of health status Measurement INstruments 143 
(COSMIN) propose a guideline for systematic reviews of measurement properties for patient-reported 144 
outcome measures (PROMs).44 As this guideline designed for PROMs include criteria that are not 145 
relevant for ClinROMs (e.g. box 2a-2c content validity), only the relevant criteria will be used in this 146 
review. The following 10 steps recommendations and instruments will be used. Steps 1 to 4 are 147 
standard procedures when performing systematic reviews. Steps 5 to 7 concern the evaluation of the 148 
measurement properties of the included instrument. Steps 8 to 10 concern the evaluation of the 149 
interpretability and feasibility of the instruments and the reporting of the instruments included in the 150 
systematic review. The COSMIN Risk of bias checklist will be followed.45 This review will focus on the 151 
development of instruments and mainly on their measures of validity and reliability. 152 
The development of instruments is evaluated through questions about the construct, the target 153 
population, the context of use, the item generation, the data analyses, the comprehensibility and 154 
comprehensiveness, as well as how the instrument was tested.46. 155 
Psychometric properties of the instruments are assessed through several types of validity. For this 156 
review, the COSMIN group taxonomy measurement will be used.  157 
Measures of validity refer to the degree to which an instrument measures the construct it has to 158 
measure. They include:  159 
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 content validity: the degree to which the content of an instrument is an adequate reflection of 160 
the construct to be measured, including face validity. Content validity is evaluated by relevant 161 
items for the construct, the target population, the comprehensiveness of the instrument and by 162 
the Content Validity Index (CVI). 163 
 construct validity: the degree to which the scores of an instrument are consistent with 164 
hypotheses based on the assumption that the instrument measures the construct to be 165 
measured. It also includes the structural validity, in other words the degree to which an 166 
instrument adequately captures the dimensionality of the construct that must be measured. 167 
Construct validity is evaluated by factor analysis. 168 
 criterion validity: the degree to which the scores of an instrument are an adequate reflection of 169 
a ‘gold standard’ criterion.45 Criterion validity is evaluated by the correlation with the gold 170 
standard and will only be considered if the gold-standard is in accordance with COSMIN 171 
guidelines.44 172 
Measures of reliability refer to the extent to which scores for patients who have not changed are the 173 
same for repeated measurement under several conditions. They include: 174 
 internal consistency: the degree of the interrelatedness among the items. It is measured by 175 
Cronbach’s alpha or KR-20. 176 
 reliability: the proportion of the total variance in the measurements which is due to ‘true’ 177 
differences between patients. It is assessed by intra-class correlation coefficients (ICC), 178 
weighted or un-weighted Kappa statistics and standard error of measurement (SEM). 179 
 measurement error: the systematic and random error of a patient’s score that is not attributable 180 
to true changes. It is measured by the Standard Error of Measurement (SEM), Smallest 181 
Detectable Change (SDC), Limits of Agreement (LoA) or a percentage of agreement.45  182 
When applicable, responsiveness – the ability to detect change over time in the construct to be 183 
measured - will be assessed using the following criteria: absolute or relative correlations or differences 184 
of the change scores, area under the Receiver Operating Curve (ROC), or sensitivity and specificity.  185 
Types of studies 186 
Any quantitative study design will be considered for inclusion in this systematic review of measurement 187 
properties; however, the included studies will be those that report on the development and/or validation 188 
of measurement instruments as described above. Studies published in English and French – authors’ 189 
commonly spoken languages - will be included. 190 
Methods 191 
The proposed systematic review will be conducted in accordance with the COSMIN methodology for 192 
systematic reviews of measurement properties for PROMs.47 The title has been registered on the JBI 193 
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registry. All the documents that will be used for this review are on the COSMIN website: 194 
https://www.cosmin.nl/cosmin-tools/.  195 
Search strategy 196 
The search strategy will aim to locate published and unpublished studies. It will be based on the 197 
COSMIN recommendations and using the precise search filter for measurement properties to capture 198 
relevant measurement properties.48 The systematic literature search will be performed in collaboration 199 
with a librarian. An initial limited search of MEDLINE and CINAHL will be conducted, followed by an 200 
analysis of text words contained in the title and abstract, and of the index terms used to describe the 201 
article. The search strategies will be adapted to the syntax and subject headings of each database. An 202 
example for a draft strategy in Medline Ovid SP is provided in Appendix I. The search will be conducted 203 
in four electronic bibliographic databases without date restrictions.  204 
Information sources 205 
The bibliographic databases to be searched will include Embase.com, Medline Ovid SP, Pubmed (NOT 206 
medline[sb]) and CINAHL EBSCO. The search for unpublished studies will include Google Scholar, 207 
government websites (i.e., National Institute of Nursing Research), hospice websites, the Library 208 
Network of Western Switzerland and WorldCat. We will also contact researchers who have recently 209 
published a paper on this topic, to make sure we are not missing on some unpublished work that could 210 
be included in this review. Finally, the reference list of all studies selected for critical appraisal will be 211 
screened for additional studies. 212 
Study selection 213 
As recommended by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 214 
(PRISMA)43, following the search, all identified citations will be collated and uploaded into EndNote X8 215 
/2016 (Clarivate Analytics, PA, USA) and duplicates removed. Titles and abstracts will then be screened 216 
by two independent reviewers (FTL & ASR) for assessment against the inclusion criteria for the review 217 
with the free software Rayyan QCRI that allows blinded assessment.49 The full text of selected citations 218 
will be assessed in detail against the inclusion criteria by two independent reviewers (FTL & ASR). 219 
Reasons for exclusion of full text studies that do not meet the inclusion criteria will be recorded and 220 
reported in the systematic review. Any disagreements that arise between the reviewers at each stage 221 
of the study selection process will be resolved with a third reviewer (CMA) and through discussion. The 222 
results of the search will be reported in full in the final systematic review and presented in a Preferred 223 
Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flow diagram.50 224 
Assessment of Methodological Quality 225 
Selected studies will be critically appraised by two independent reviewers for methodological quality 226 
using the standardized critical appraisal instrument from COSMIN methodology and instruments 227 
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(https://www.cosmin.nl/wp-content/uploads/COSMIN-RoB-checklist-V2-0-v17_rev3.pdf). “The result of 228 
each study on a measurement property should be rated against the updated criteria for good 229 
measurement properties. Each result is rated as either sufficient (+), insufficient (–), or indeterminate 230 
(?)”.47 [p.28] Any disagreements that arise will be resolved with a third reviewer and through discussion. 231 
Following critical appraisal, the decision to exclude or not studies will be based on the COSMIN 232 
recommendations. 233 
Data Extraction 234 
Data will be extracted from included studies, using the modified pilot tested data extraction form 235 
(Appendix II) by two independent reviewers (FTL & ASR). The data extracted will include specific details 236 
about the tests, populations, study methods and outcomes of significance to the review question and 237 
specific objectives. Any disagreements that arise between the reviewers will be solved through 238 
discussion, and if no consensus can be found a third reviewer (CMA) will be involved. Authors of papers 239 
will be contacted to request missing or additional data where required. 240 
Data Synthesis 241 
The results will be quantitatively pooled or qualitatively summarized. They will be reported in a table 242 
with the rating of the pooled or summarized results and the grading of the quality of evidence (high, 243 
moderate, low, very low). “If possible, the results from different studies on one measurement property 244 
should be statistically pooled in a meta‐analysis. Pooled estimates of measurement properties can be 245 
obtained by calculating weighted means (based on the number of participants included per study) and 246 
95% confidence intervals”.47[p.31] This meta-analysis will be performed by a statistician. The strategy for 247 
meta-analysis will be based on the COSMIN guide. Where statistical pooling is not possible the findings 248 
will be presented in narrative form including tables and figures to aid in data presentation where 249 
appropriate. 250 
Assessing Confidence 251 
Grading of the quality will be based on a modified GRADE approach, where the quality of the evidence 252 
is graded as high, moderate, low, or very low evidence.45 “For evaluating measurement properties of 253 
systematic reviews of PROMs, the following four factors should be taken into account: (1) risk of bias 254 
(i.e. the methodological quality of the studies), (2) inconsistency (i.e. unexplained inconsistency of 255 
results across studies), (3) imprecision (i.e. total sample size of the available studies), and (4) 256 
indirectness (i.e. evidence from different populations than the population of interest in the review)”.47[p.32] 257 
A 'summary of findings' table will be created using GRADEPro GDT software.  258 
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Appendices 393 
Appendix I: Search Strategy 394 
Overview of the Medline Ovid SP search strategy  395 
(exp palliative care/ OR terminal care/ OR exp terminally ill/ OR exp palliative medicine/ OR exp hospice 396 
and palliative care nursing/ OR (palliative OR "terminally ill" OR (terminal ADJ1 (care OR disease* OR 397 
patient*))).ab,ti,kf.) AND (exp patient selection/ OR exp transitional care/ OR referral and consultation/ 398 
OR needs assessment/ OR (identification OR identify OR identifying OR referral OR (patient* ADJ3 399 
selection*) OR (transition* ADJ3 care) OR (assessment* ADJ6 (need OR needs))).ab,ti,kf.) AND 400 
(surveys and questionnaires/ OR (tool OR tools OR questionnaire* OR instrument OR instruments OR 401 
scale OR scales OR (surprise* ADJ3 question*) OR "gold standards framework" OR "gold standard 402 
framework" OR NECPAL OR SPICT OR RADPAC OR HR-PRO OR NAT OR PC-NAT OR GSF OR 403 
CriSTAL OR SPICT OR DanPaCT OR P-caREs).ab,ti,kf.)  404 
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Appendix II: Data Extraction Instrument 405 
 406 
Data extraction form for studies of measurement properties 407 
 408 








Study details  417 
Study design: 418 
Instrument(s) assessed (sub-scales if applicable): 419 
Construct assessed: 420 
Country (language) in which instrument assessed: 421 
Mode of administration (e.g. online, paper-based, etc.): 422 
Setting/Context: 423 
Participant Characteristics (study inclusion/exclusion information): 424 
Description of main results (measurement properties) for each instrument: 425 
Reviewer comments: 426 
 427 
 428 
 429 
